Saturday , October 21 2017
Home / Letter From The Editor / Letter from the Editor #593

Letter from the Editor #593

Over the past year we have run a lot of articles on the Patient Centered Medical Home and Shared Medical Visits. This past week, however, I may have found the most useful information yet. I was able to listen to a public briefing on how CMS plans to reward clinicians for using the Medical Home model. Check out the special feature Getting Paid For Patient Centered Medical Homes and find out how much each patient will be worth.

Often times we see that old drugs find new uses in the treatment of diabetes. Recently bromocriptine was approved for treating patients and this week’s Item #12, Salsalate Improves Glycemic Control in Newly Diagnosed Type 2’s, brings a new study that shows salsalate, an old anti-inflammatory medication, improves glycemia in newly diagnosed drug-naive patients with T2DM. The results are very good and hopefully soon we will have enough data to share this medication with our “Diabetics in Denial.”

*****

Announcements:

TCOYD Conference and Health Fair, San Diego Convention Center, San Diego, California, Saturday, November 12, 2011

Join Steven Edelman, MD and Charlie Kimball, IZOD Indy Car Driver; Phil Southerland, Professional Cyclist, Founder, Team Type 1; and Ben Vereen, Singer, Dancer, and Actor, for a day focused on diabetes health and wellness.

dLife.com: October 2, 7PM ET on CNBC

Topics: An American Idol shares her diabetes challenges on the road to fame, and Jim Turner hits the streets to talk about diabetes fears. Plus, a low carb salad with a sweet and sour twist in the dLife kitchen. Special Guests: Crystal Bowersox and Toby Peterson. Sundays on CNBC at 7 PM ET, 6 PM CT, and 4 PM PT. Catch up on dLife.com.

Please answer this week’s poll: When do you think there might be a cure for type 1 diabetes?

Vote in and then see results from previous polls here.

*****************************
We can make a difference!
*****************************

Check out this week’s “Test Your Diabetes Knowledge” question!

Dave Joffe, Editor-in-chief